Sbir 1 in-suit detection of venous gas emboli
Ended Definitive Contract Awarded Last action
- Contract number
- 80NSSC25C0180
- Awardee
-
Creare LLC UEI JDKYAKDT4TT6
- Awarding agency
-
Shared Services Center
National Aeronautics and Space Administration
- Obligated
- $149,920
Award facts
- Contract value 100% obligated
- $149,920.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 500 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Hanover, NH 03755, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $149,920 |
About this award
The U.S. government awarded Creare LLC a $149,920 Phase I Small Business Innovation Research (SBIR) contract on September 29, 2025, for the development of in-situ detection technology for venous gas emboli. This 18-month effort, set aside exclusively for small businesses, will be performed in Hanover, New Hampshire, and is scheduled for completion by March 27, 2026. The contract is funded through a Civilian agency's Shared Services Center under a firm fixed-price arrangement. Creare's role will be to advance detection methodologies that can identify venous gas emboli during medical procedures or monitoring scenarios, addressing a critical need in aerospace medicine and clinical settings.
Creare LLC, a small business engineering research and development firm headquartered in Hanover, New Hampshire, brings substantial expertise in medical device development and specialized sensor technologies to this initiative. The company has an established track record with federal agencies including NASA, the Department of Defense, and the National Institutes of Health, with particular strength in designing innovative medical technologies and advanced sensing systems. This Phase I award represents a foundational investment in exploring the feasibility and technical approach for real-time detection of venous gas emboli, with potential applications in both clinical medicine and aerospace operations. Success in this phase could position the technology for further development and commercialization through subsequent SBIR funding opportunities.
Quick answers
Who was awarded contract 80NSSC25C0180?
80NSSC25C0180 was awarded to Creare LLC by Shared Services Center (National Aeronautics and Space Administration) on September 29, 2025.
How much is contract 80NSSC25C0180 worth?
The government has obligated $149,920 on 80NSSC25C0180.
Was contract 80NSSC25C0180 competed?
The extent of competition for 80NSSC25C0180 was full and open competition after exclusion of sources. The government received 500 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award